Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 18, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Philip Shen Reiterated (BPTH) at Strong Buy and Held Target at $40 on, Apr 18th, 2024
Philip Shen of Roth MKM, Reiterated "Bio-Path Holdings, Inc." (BPTH) at Strong Buy and Held Target at $40 on, Apr 18th, 2024.
Philip has made no other calls on BPTH in the last 4 months.
There is 1 other peer that has a rating on BPTH. Out of the 1 peers that are also analyzing BPTH, 0 agree with Philip's Rating of Hold.
This is the rating of the analyst that currently disagrees with Philip
- Jonathan Aschoff of "Roth MKM" Maintained at Strong Buy with Increased Target to $40 on, Wednesday, March 27th, 2024
